Advisory Research’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,738
Closed -$861K 380
2021
Q1
$861K Buy
4,738
+1,195
+34% +$277K 0.06% 221
2020
Q4
$708K Buy
3,543
+1,218
+52% +$248K 0.05% 228
2020
Q3
$510K Sell
2,325
-4,952
-68% -$1.05M 0.05% 237
2020
Q2
$1.39M Sell
7,277
-11,975
-62% -$2.1M 0.12% 139
2020
Q1
$2.98M Sell
19,252
-16,847
-47% -$1.96M 0.21% 70
2019
Q4
$3.02M Sell
36,099
-4,301
-11% -$327K 0.14% 92
2019
Q3
$2.74M Sell
40,400
-10,705
-21% -$705K 0.13% 100
2019
Q2
$3.39M Buy
51,105
+15,723
+44% +$916K 0.07% 145
2019
Q1
$1.97M Sell
35,382
-26,301
-43% -$1.61M 0.04% 186
2018
Q4
$3.06M Sell
61,683
-10,899
-15% -$667K 0.06% 155
2018
Q3
$6.27M Sell
72,582
-24,718
-25% -$1.76M 0.1% 129
2018
Q2
$5.65M Sell
97,300
-35,622
-27% -$1.74M 0.09% 141
2018
Q1
$5.36M Buy
132,922
+13,053
+11% +$493K 0.1% 137
2017
Q4
$4.18M Sell
119,869
-16,448
-12% -$546K 0.07% 162
2017
Q3
$4.52M Buy
136,317
+18,260
+15% +$599K 0.07% 154
2017
Q2
$4.1M Buy
118,057
+87,593
+288% +$2.55M 0.06% 166
2017
Q1
$762K Buy
+30,464
New +$634K 0.01% 339

Other funds holding TDOC

Advisory Research's TDOC Position: Q2 2021 in Review

Advisory Research sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 4,738 shares — an estimated $861K sold.

Advisory Research first reported a position in TDOC in Q1 2017 and held it in 17 quarters. The position peaked at $6.27M in Q3 2018. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • Advisory Research reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
  • Advisory Research sold 4,738 Teladoc Health shares in Q2 2021, an estimated $861K.
  • Advisory Research first reported a position in Teladoc Health in Q1 2017 and held it in 17 quarters.
  • Advisory Research's Teladoc Health position peaked at $6.27M in Q3 2018.
  • 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Advisory Research's 13F filing for Q2 2021, filed 16 Aug 2021.